Are natural products still of interest compared with molecular-targeted therapy for the treatment of cancer?
Raymond
Eric
E
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use*; D016503:Drug Delivery Systems; D006133:Growth Substances / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D015398:Signal Transduction
D000911:Antibodies, Monoclonal; D001688:Biological Products; D006133:Growth Substances